Satoris Launches Protein-Based Parkinson's Study with Grant from Michael J. Fox Foundation
November 06, 2009
Satoris Launches Protein-Based Parkinson's Study with Grant from Michael J. Fox Foundation
Satoris will use a panel of 500 signaling proteins and antibody-based quantitative nitrocellulose filter membrane array technology to search for candidate biomarkers for the disease. In May, it launched its first commercial products, protein panels for Alzheimer's disease and dementia.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Satoris Named Global Distributor of RBM's 189-marker DiscoveryMAP Neurology Panel
August 6, 2009 / ProteoMonitor - Samples Available for PRG 2012 Intra-Lab QC and Reproducibility Study
January 13, 2012 / ProteoMonitor - People in the News: Eric Bouvier; Alan Marshall; and More
January 13, 2012 / ProteoMonitor - NCI Kicks Off Second Stage of Clinical Proteomic Technologies for Cancer Initiative
August 26, 2011 / ProteoMonitor - Yale-Led Group Links Protein Markers to Kidney Injury in Cardiac Surgery Patients
August 26, 2011 / ProteoMonitor